|
APIP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.22820000123281E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.34470000082254E-08 |
| Normal-vs-Stage2 |
1.5794999996821E-07 |
| Normal-vs-Stage3 |
1.584860E-04 |
| Normal-vs-Stage4 |
8.37220000000638E-05 |
| Stage1-vs-Stage2 |
9.796400E-01 |
| Stage1-vs-Stage3 |
2.145600E-01 |
| Stage1-vs-Stage4 |
6.110600E-01 |
| Stage2-vs-Stage3 |
2.706200E-01 |
| Stage2-vs-Stage4 |
6.410200E-01 |
| Stage3-vs-Stage4 |
2.839000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.02329999818585E-08 |
| Normal-vs-AfricanAmerican |
9.44869960051165E-10 |
| Normal-vs-Asian |
1.700960E-01 |
| Caucasian-vs-AfricanAmerican |
7.067000E-01 |
| Caucasian-vs-Asian |
3.597200E-01 |
| AfricanAmerican-vs-Asian |
3.343200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.71920000457959E-08 |
| Normal-vs-Female |
8.26509999996006E-07 |
| Male-vs-Female |
2.188200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.16060000499019E-08 |
| Normal-vs-Extreme_Weight |
1.50960000055989E-08 |
| Normal-vs-Obese |
6.53770000358378E-08 |
| Normal-vs-Extreme_Obese |
2.724100E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.540400E-01 |
| Normal_Weight-vs-Obese |
9.903400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.989000E-01 |
| Extreme_Weight-vs-Obese |
4.467800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.912000E-01 |
| Obese-vs-Extreme_Obese |
7.579800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.79773999999799E-05 |
| Normal-vs-Age(41-60Yrs) |
6.84319999555427E-08 |
| Normal-vs-Age(61-80Yrs) |
2.47860000301969E-08 |
| Normal-vs-Age(81-100Yrs) |
3.388800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.043000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.110600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.688200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.040000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.289000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.494000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.33560004459355E-09 |
| Normal-VS-Type2 PRCC |
3.5959999999946E-07 |
| Normal-VS-KIRP CIMP |
5.98329999990099E-08 |
| Normal-VS-Unclassified PRCC |
5.16469999989333E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.377760E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.527800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.960100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.450440E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.531600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.223590E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.71589999998068E-07 |
| Normal-vs-N1 |
1.584740E-04 |
| Normal-vs-N2 |
1.962130E-03 |
| N0-vs-N1 |
4.423600E-01 |
| N0-vs-N2 |
1.093810E-01 |
| N1-vs-N2 |
6.984000E-02 |
|
|
